Terumo Corporation (TRUMY)
USD 19.28
(-2.92%)
USD 19.28
(-2.92%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 504.3 Billion JPY | 2.68% |
| 2023 | 491.16 Billion JPY | 6.45% |
| 2022 | 461.38 Billion JPY | -6.7% |
| 2021 | 494.53 Billion JPY | 1.66% |
| 2020 | 486.47 Billion JPY | 15.09% |
| 2019 | 422.67 Billion JPY | -20.03% |
| 2018 | 528.54 Billion JPY | -0.62% |
| 2017 | 531.85 Billion JPY | 36.32% |
| 2016 | 390.14 Billion JPY | -6.79% |
| 2015 | 418.55 Billion JPY | 24.36% |
| 2014 | 336.56 Billion JPY | 1.03% |
| 2013 | 333.12 Billion JPY | -2.02% |
| 2012 | 339.98 Billion JPY | 301.96% |
| 2011 | 84.58 Billion JPY | -21.95% |
| 2010 | 108.36 Billion JPY | 7.4% |
| 2009 | 100.89 Billion JPY | -17.27% |
| 2008 | 121.96 Billion JPY | 56.7% |
| 2007 | 77.83 Billion JPY | -4.2% |
| 2006 | 81.23 Billion JPY | -12.19% |
| 2005 | 92.51 Billion JPY | -6.3% |
| 2004 | 98.73 Billion JPY | -4.69% |
| 2003 | 103.59 Billion JPY | -1.1% |
| 2002 | 104.74 Billion JPY | -4.15% |
| 2001 | 109.27 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 468.13 Billion JPY | -4.69% |
| 2024 Q4 | 504.3 Billion JPY | 6.02% |
| 2024 FY | 504.3 Billion JPY | 2.68% |
| 2024 Q3 | 475.65 Billion JPY | -2.41% |
| 2024 Q2 | 487.4 Billion JPY | 4.11% |
| 2023 Q3 | 469.75 Billion JPY | -3.7% |
| 2023 FY | 491.16 Billion JPY | 6.45% |
| 2023 Q1 | 466.85 Billion JPY | 1.19% |
| 2023 Q2 | 487.82 Billion JPY | 4.49% |
| 2023 Q4 | 491.16 Billion JPY | 4.56% |
| 2022 FY | 461.38 Billion JPY | -6.7% |
| 2022 Q3 | 465.61 Billion JPY | 0.13% |
| 2022 Q4 | 461.38 Billion JPY | -0.91% |
| 2022 Q2 | 465.02 Billion JPY | -0.11% |
| 2022 Q1 | 465.55 Billion JPY | -5.86% |
| 2021 Q2 | 523.07 Billion JPY | -1.05% |
| 2021 FY | 494.53 Billion JPY | 1.66% |
| 2021 Q4 | 494.53 Billion JPY | 2.73% |
| 2021 Q3 | 481.41 Billion JPY | -7.97% |
| 2021 Q1 | 528.64 Billion JPY | 8.67% |
| 2020 FY | 486.47 Billion JPY | 15.09% |
| 2020 Q3 | 433.05 Billion JPY | 0.8% |
| 2020 Q4 | 486.47 Billion JPY | 12.33% |
| 2020 Q1 | 435.66 Billion JPY | 3.07% |
| 2020 Q2 | 429.63 Billion JPY | -1.38% |
| 2019 Q1 | 494.62 Billion JPY | -6.42% |
| 2019 FY | 422.67 Billion JPY | -20.03% |
| 2019 Q4 | 422.67 Billion JPY | -7.61% |
| 2019 Q2 | 456.85 Billion JPY | -7.63% |
| 2019 Q3 | 457.47 Billion JPY | 0.13% |
| 2018 Q2 | 545.52 Billion JPY | 1.51% |
| 2018 Q3 | 531.36 Billion JPY | -2.6% |
| 2018 Q4 | 528.54 Billion JPY | -0.53% |
| 2018 Q1 | 537.41 Billion JPY | 1.05% |
| 2018 FY | 528.54 Billion JPY | -0.62% |
| 2017 Q1 | 392.73 Billion JPY | 0.66% |
| 2017 FY | 531.85 Billion JPY | 36.32% |
| 2017 Q4 | 531.85 Billion JPY | 1.72% |
| 2017 Q3 | 522.86 Billion JPY | 28.18% |
| 2017 Q2 | 407.9 Billion JPY | 3.86% |
| 2016 Q1 | 394.67 Billion JPY | -5.7% |
| 2016 FY | 390.14 Billion JPY | -6.79% |
| 2016 Q4 | 390.14 Billion JPY | -0.15% |
| 2016 Q3 | 390.72 Billion JPY | -1.31% |
| 2016 Q2 | 395.89 Billion JPY | 0.31% |
| 2015 Q1 | 315.94 Billion JPY | -6.13% |
| 2015 FY | 418.55 Billion JPY | 24.36% |
| 2015 Q4 | 418.55 Billion JPY | -6.76% |
| 2015 Q2 | 330.65 Billion JPY | 4.66% |
| 2015 Q3 | 448.88 Billion JPY | 35.76% |
| 2014 Q2 | 332.57 Billion JPY | -0.32% |
| 2014 Q3 | 351.91 Billion JPY | 5.82% |
| 2014 FY | 336.56 Billion JPY | 1.03% |
| 2014 Q1 | 333.65 Billion JPY | 0.16% |
| 2014 Q4 | 336.56 Billion JPY | -4.36% |
| 2013 Q1 | 312.54 Billion JPY | -8.07% |
| 2013 FY | 333.12 Billion JPY | -2.02% |
| 2013 Q4 | 333.12 Billion JPY | 0.93% |
| 2013 Q3 | 330.05 Billion JPY | 6.49% |
| 2013 Q2 | 309.94 Billion JPY | -0.83% |
| 2012 Q3 | 328.33 Billion JPY | -7.51% |
| 2012 FY | 339.98 Billion JPY | 301.96% |
| 2012 Q1 | 355.63 Billion JPY | 320.47% |
| 2012 Q2 | 354.99 Billion JPY | -0.18% |
| 2012 Q4 | 339.98 Billion JPY | 3.55% |
| 2011 Q1 | 84.08 Billion JPY | -22.41% |
| 2011 Q3 | 70.54 Billion JPY | -20.34% |
| 2011 Q2 | 88.56 Billion JPY | 5.32% |
| 2011 Q4 | 84.58 Billion JPY | 19.89% |
| 2011 FY | 84.58 Billion JPY | -21.95% |
| 2010 FY | 108.36 Billion JPY | 7.4% |
| 2010 Q4 | 108.36 Billion JPY | 13.11% |
| 2010 Q3 | 95.8 Billion JPY | -4.13% |
| 2010 Q2 | 99.93 Billion JPY | 0.0% |
| 2009 Q4 | 100.89 Billion JPY | 1.17% |
| 2009 Q3 | 99.73 Billion JPY | 0.0% |
| 2009 FY | 100.89 Billion JPY | -17.27% |
| 2008 FY | 121.96 Billion JPY | 56.7% |
| 2007 FY | 77.83 Billion JPY | -4.2% |
| 2006 FY | 81.23 Billion JPY | -12.19% |
| 2005 FY | 92.51 Billion JPY | -6.3% |
| 2004 FY | 98.73 Billion JPY | -4.69% |
| 2003 FY | 103.59 Billion JPY | -1.1% |
| 2002 FY | 104.74 Billion JPY | -4.15% |
| 2001 FY | 109.27 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -21461282.117% |
| Ansell Limited | 1.32 Billion USD | -37820.645% |
| Ansell Limited | 1.33 Billion USD | -37749.67% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -399075.22% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -53469362.622% |
| Psykey, Inc. | 2.47 Million USD | -20384100.768% |
| ConvaTec Group Plc | 2.01 Billion USD | -24888.723% |
| ConvaTec Group Plc | 2.02 Billion USD | -24853.439% |
| Encision Inc. | 1.98 Million USD | -25419110.39% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -16586398.377% |
| Innovative MedTech Inc. | 6.13 Million USD | -8220305.966% |
| LifePoint, Inc. | 2.45 Million USD | -20548973.841% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -4953332.865% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -14832517.647% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -16587249.436% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -64960631.855% |
| SmileDirectClub, Inc. | 982.26 Million USD | -51241.65% |
| Sector 10, Inc. | 9.84 Million USD | -5122165.888% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | -37098.99% |
| SheerVision, Inc. | 1.43 Million USD | -35231697.055% |
| United Health Products, Inc. | 1.99 Million USD | -25229617.405% |
| Vasamed, Inc. | 1 Million USD | -50164925.366% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -13270194.202% |
| Yubo International Biotech Limited | 2.91 Million USD | -17306768.676% |